title: Regulation of the incorporation of tissue factor into microparticles by serine phosphorylation of the cytoplasmic domain of tissue factor.
abstract: The mechanisms that regulate the incorporation and release of tissue factors (TFs) into cell-derived microparticles are as yet unidentified. In this study, we have explored the regulation of TF release into microparticles by the phosphorylation of serine residues within the cytoplasmic domain of TF. Wild-type and mutant forms of TF, containing alanine and aspartate substitutions at Ser253 and Ser258, were overexpressed in coronary artery and dermal microvascular endothelial cells and microparticle release stimulated with PAR2 agonist peptide (PAR2-AP). The release of TF antigen and activity was then monitored. In addition, the phosphorylation state of the two serine residues within the released microparticles and the cells was monitored for 150 min. The release of wild-type TF as procoagulant microparticles peaked at 90 min and declined thereafter in both cell types. The TF within these microparticles was phosphorylated at Ser253 but not at Ser258. Aspartate substitution of Ser253 resulted in rapid release of TF antigen but not activity, whereas TF release was reduced and delayed by alanine substitution of Ser253 or aspartate substitution of Ser258. Alanine substitution of Ser258 prolonged the release of TF following PAR2-AP activation. The release of TF was concurrent with phosphorylation of Ser253 and was followed by dephosphorylation at 120 min and phosphorylation of Ser258. We propose a sequential mechanism in which the phosphorylation of Ser253 through PAR2 activation results in the incorporation of TF into microparticles, simultaneously inducing Ser258 phosphorylation. Phosphorylation of Ser258 in turn promotes the dephosphorylation of Ser253 and suppresses the release of TF.
authors.affiliation: Biomedical Section, Department of Biological Sciences, University of Hull, Cottingham Road, Hull HU6 7RX, United Kingdom.
authors.forename: Mary E W
authors.initials: ME
authors.lastname: Collier
authors.forename: Camille
authors.initials: C
authors.lastname: Ettelaie
mesh_terms: D000409:Alanine / Q000235:genetics / Q000378:metabolism; D017209:Apoptosis / Q000187:drug effects; D001224:Aspartic Acid / Q000235:genetics / Q000378:metabolism; D015153:Blotting, Western; D055252:Cell-Derived Microparticles / Q000187:drug effects / Q000378:metabolism*; D002478:Cells, Cultured; D006801:Humans; D009842:Oligopeptides / Q000494:pharmacology; D010766:Phosphorylation / Q000187:drug effects; D012694:Serine / Q000235:genetics / Q000378:metabolism*; D015398:Signal Transduction / Q000187:drug effects; D013925:Thromboplastin / Q000235:genetics / Q000378:metabolism*
chemical_list: C487404:2-furoyl-LIGRLO-amide; D009842:Oligopeptides; D001224:Aspartic Acid; D012694:Serine; D013925:Thromboplastin; D000409:Alanine